2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5
AssigneeAgomab Spain, S.L.U.
InventorsRamón BOSSER ARTAL, Begoña PAMPÍN CASAL, Julio CASTRO PALOMINO LARIA
Life of this patent
Estimating the term…